Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Women without a history of endometrial cancer or complex atypical hyperplasia ("unaffected women"):
- Women who are at least 18 years old
- Women who can read and speak English or Spanish
- Women who have not yet gone through menopause
- Women who have no prior history of endometrial cancer or a condition called complex atypical hyperplasia (a type of abnormal uterine cell growth)
- Women who are able to take part in an interview without physical, psychological, or cognitive barriers, as assessed by the research team
- Women who are willing to sign a written consent form
Women with a history of endometrial cancer or complex atypical hyperplasia ("affected women"):
- Women who are at least 18 years old
- Women who can read and speak English or Spanish
- Women who have a prior history of endometrial cancer or complex atypical hyperplasia
- Women who are able to take part in an interview without physical, psychological, or cognitive barriers, as assessed by the research team
- Women who are willing to sign a written consent form
Healthcare providers:
- Doctors or advanced practice providers (such as physician assistants or nurse practitioners) working in Family Medicine, Obstetrics & Gynecology, Internal Medicine, or Endocrinology
- Those who are at least 18 years old
- Those who can read and speak English or Spanish
- Those who are willing to sign a written consent form for a qualitative interview
Who may not be able to join:
- No specific exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Larissa A Meyer, MD, M.D. Anderson Cancer Center
Phone: 713-745-0973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient Utility Questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.